Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PrEP-3D RCT: A Randomized Controlled Trial Evaluating An Integrated Pharmacy Digital Diary and Delivery Strategy to Increase PrEP Use Among Persons Assigned Male at Birth Who Have Sex With Persons Assigned Male at Birth

NCT05474313 is registered in ClinicalTrials.gov with Public Health Foundation Enterprises, Inc. as lead sponsor.

NCT NCT05474313
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05474313 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PrEP-3D RCT: A Randomized Controlled Trial Evaluating An Integrated Pharmacy Digital Diary and Delivery Strategy to Increase PrEP Use Among Persons Assigned Male at Birth Who Have Sex With Persons Assigned Male at Birth
Lead sponsor
Public Health Foundation Enterprises, Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
April 8, 2022
Completion date
December 31, 2023
Enrollment
150 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

adherence, medication, hiv prevention, pre-exposure prophylaxis (prep), risk reduction